The comparative study to evaluate the effect of palonosetron monotherapy versus palonosetron with dexamethasone combination therapy for prevention of postoperative nausea and vomiting

Background5-hydroxytryptamine type 3 (5-HT3) receptor antagonists are effective and safe on postoperative nausea and vomiting (PONV). Palonosetron, the newest 5-HT3 antagonist, has potent antiemetic property. We hypothesized that a combination of palonosetron and dexamethasone could more decrease PO...

Full description

Bibliographic Details
Main Authors: Jung Woo Park, Jin Woo Jun, Yun Hee Lim, Sang Seok Lee, Byung Hoon Yoo, Kye-Min Kim, Jun Heum Yon, Ki Hyuk Hong
Format: Article
Language:English
Published: Korean Society of Anesthesiologists 2012-10-01
Series:Korean Journal of Anesthesiology
Subjects:
Online Access:http://ekja.org/upload/pdf/kjae-63-334.pdf
_version_ 1818562338595274752
author Jung Woo Park
Jin Woo Jun
Yun Hee Lim
Sang Seok Lee
Byung Hoon Yoo
Kye-Min Kim
Jun Heum Yon
Ki Hyuk Hong
author_facet Jung Woo Park
Jin Woo Jun
Yun Hee Lim
Sang Seok Lee
Byung Hoon Yoo
Kye-Min Kim
Jun Heum Yon
Ki Hyuk Hong
author_sort Jung Woo Park
collection DOAJ
description Background5-hydroxytryptamine type 3 (5-HT3) receptor antagonists are effective and safe on postoperative nausea and vomiting (PONV). Palonosetron, the newest 5-HT3 antagonist, has potent antiemetic property. We hypothesized that a combination of palonosetron and dexamethasone could more decrease PONV than palonosetron alone.MethodsAmong the patients scheduled to undergo laparoscopic gynecologic surgery, mastoidectomy with tympanoplasty or thyroidectomy under general anesthesia, eighty four female patients with at least two PONV risk factors were enrolled in this study. They were received randomly 0.075 mg palonosetron and 4 mg dexamethasone (group C) or 0.075 mg palonosetron alone (group P). The severity of PONV using Rhodes index and the percentage of complete response during postoperative 24 hours were compared between groups.ResultsThe frequency of mild/moderate/great/severe PONV based on Rhodes index were 9.8%/0%/0%/0% and 9.3%/2.3%/2.3%/0% in group P and group C, respectively. Complete response for PONV was observed in 90.2% and 86% of patients in group P and group C, respectively. The overall incidence of PONV in group P and C was 9.8% and 14%, respectively. There was no significant difference between the two groups.ConclusionsThere were no differences between palonosetron monotherapy and combination therapy of palonosetron and dexamethasone in patients with high emetogenic risk.
first_indexed 2024-12-14T01:02:23Z
format Article
id doaj.art-d536771370794c18a79ec219141d81b0
institution Directory Open Access Journal
issn 2005-6419
2005-7563
language English
last_indexed 2024-12-14T01:02:23Z
publishDate 2012-10-01
publisher Korean Society of Anesthesiologists
record_format Article
series Korean Journal of Anesthesiology
spelling doaj.art-d536771370794c18a79ec219141d81b02022-12-21T23:23:10ZengKorean Society of AnesthesiologistsKorean Journal of Anesthesiology2005-64192005-75632012-10-0163433433910.4097/kjae.2012.63.4.3347431The comparative study to evaluate the effect of palonosetron monotherapy versus palonosetron with dexamethasone combination therapy for prevention of postoperative nausea and vomitingJung Woo Park0Jin Woo Jun1Yun Hee Lim2Sang Seok Lee3Byung Hoon Yoo4Kye-Min Kim5Jun Heum Yon6Ki Hyuk Hong7Department of Anesthesiology and Pain Medicine, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea.Department of Anesthesiology and Pain Medicine, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea.Department of Anesthesiology and Pain Medicine, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea.Department of Anesthesiology and Pain Medicine, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea.Department of Anesthesiology and Pain Medicine, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea.Department of Anesthesiology and Pain Medicine, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea.Department of Anesthesiology and Pain Medicine, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea.Department of Anesthesiology and Pain Medicine, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea.Background5-hydroxytryptamine type 3 (5-HT3) receptor antagonists are effective and safe on postoperative nausea and vomiting (PONV). Palonosetron, the newest 5-HT3 antagonist, has potent antiemetic property. We hypothesized that a combination of palonosetron and dexamethasone could more decrease PONV than palonosetron alone.MethodsAmong the patients scheduled to undergo laparoscopic gynecologic surgery, mastoidectomy with tympanoplasty or thyroidectomy under general anesthesia, eighty four female patients with at least two PONV risk factors were enrolled in this study. They were received randomly 0.075 mg palonosetron and 4 mg dexamethasone (group C) or 0.075 mg palonosetron alone (group P). The severity of PONV using Rhodes index and the percentage of complete response during postoperative 24 hours were compared between groups.ResultsThe frequency of mild/moderate/great/severe PONV based on Rhodes index were 9.8%/0%/0%/0% and 9.3%/2.3%/2.3%/0% in group P and group C, respectively. Complete response for PONV was observed in 90.2% and 86% of patients in group P and group C, respectively. The overall incidence of PONV in group P and C was 9.8% and 14%, respectively. There was no significant difference between the two groups.ConclusionsThere were no differences between palonosetron monotherapy and combination therapy of palonosetron and dexamethasone in patients with high emetogenic risk.http://ekja.org/upload/pdf/kjae-63-334.pdfdexamethasonepalonosetronponv
spellingShingle Jung Woo Park
Jin Woo Jun
Yun Hee Lim
Sang Seok Lee
Byung Hoon Yoo
Kye-Min Kim
Jun Heum Yon
Ki Hyuk Hong
The comparative study to evaluate the effect of palonosetron monotherapy versus palonosetron with dexamethasone combination therapy for prevention of postoperative nausea and vomiting
Korean Journal of Anesthesiology
dexamethasone
palonosetron
ponv
title The comparative study to evaluate the effect of palonosetron monotherapy versus palonosetron with dexamethasone combination therapy for prevention of postoperative nausea and vomiting
title_full The comparative study to evaluate the effect of palonosetron monotherapy versus palonosetron with dexamethasone combination therapy for prevention of postoperative nausea and vomiting
title_fullStr The comparative study to evaluate the effect of palonosetron monotherapy versus palonosetron with dexamethasone combination therapy for prevention of postoperative nausea and vomiting
title_full_unstemmed The comparative study to evaluate the effect of palonosetron monotherapy versus palonosetron with dexamethasone combination therapy for prevention of postoperative nausea and vomiting
title_short The comparative study to evaluate the effect of palonosetron monotherapy versus palonosetron with dexamethasone combination therapy for prevention of postoperative nausea and vomiting
title_sort comparative study to evaluate the effect of palonosetron monotherapy versus palonosetron with dexamethasone combination therapy for prevention of postoperative nausea and vomiting
topic dexamethasone
palonosetron
ponv
url http://ekja.org/upload/pdf/kjae-63-334.pdf
work_keys_str_mv AT jungwoopark thecomparativestudytoevaluatetheeffectofpalonosetronmonotherapyversuspalonosetronwithdexamethasonecombinationtherapyforpreventionofpostoperativenauseaandvomiting
AT jinwoojun thecomparativestudytoevaluatetheeffectofpalonosetronmonotherapyversuspalonosetronwithdexamethasonecombinationtherapyforpreventionofpostoperativenauseaandvomiting
AT yunheelim thecomparativestudytoevaluatetheeffectofpalonosetronmonotherapyversuspalonosetronwithdexamethasonecombinationtherapyforpreventionofpostoperativenauseaandvomiting
AT sangseoklee thecomparativestudytoevaluatetheeffectofpalonosetronmonotherapyversuspalonosetronwithdexamethasonecombinationtherapyforpreventionofpostoperativenauseaandvomiting
AT byunghoonyoo thecomparativestudytoevaluatetheeffectofpalonosetronmonotherapyversuspalonosetronwithdexamethasonecombinationtherapyforpreventionofpostoperativenauseaandvomiting
AT kyeminkim thecomparativestudytoevaluatetheeffectofpalonosetronmonotherapyversuspalonosetronwithdexamethasonecombinationtherapyforpreventionofpostoperativenauseaandvomiting
AT junheumyon thecomparativestudytoevaluatetheeffectofpalonosetronmonotherapyversuspalonosetronwithdexamethasonecombinationtherapyforpreventionofpostoperativenauseaandvomiting
AT kihyukhong thecomparativestudytoevaluatetheeffectofpalonosetronmonotherapyversuspalonosetronwithdexamethasonecombinationtherapyforpreventionofpostoperativenauseaandvomiting
AT jungwoopark comparativestudytoevaluatetheeffectofpalonosetronmonotherapyversuspalonosetronwithdexamethasonecombinationtherapyforpreventionofpostoperativenauseaandvomiting
AT jinwoojun comparativestudytoevaluatetheeffectofpalonosetronmonotherapyversuspalonosetronwithdexamethasonecombinationtherapyforpreventionofpostoperativenauseaandvomiting
AT yunheelim comparativestudytoevaluatetheeffectofpalonosetronmonotherapyversuspalonosetronwithdexamethasonecombinationtherapyforpreventionofpostoperativenauseaandvomiting
AT sangseoklee comparativestudytoevaluatetheeffectofpalonosetronmonotherapyversuspalonosetronwithdexamethasonecombinationtherapyforpreventionofpostoperativenauseaandvomiting
AT byunghoonyoo comparativestudytoevaluatetheeffectofpalonosetronmonotherapyversuspalonosetronwithdexamethasonecombinationtherapyforpreventionofpostoperativenauseaandvomiting
AT kyeminkim comparativestudytoevaluatetheeffectofpalonosetronmonotherapyversuspalonosetronwithdexamethasonecombinationtherapyforpreventionofpostoperativenauseaandvomiting
AT junheumyon comparativestudytoevaluatetheeffectofpalonosetronmonotherapyversuspalonosetronwithdexamethasonecombinationtherapyforpreventionofpostoperativenauseaandvomiting
AT kihyukhong comparativestudytoevaluatetheeffectofpalonosetronmonotherapyversuspalonosetronwithdexamethasonecombinationtherapyforpreventionofpostoperativenauseaandvomiting